UniProt ID | NCOA5_HUMAN | |
---|---|---|
UniProt AC | Q9HCD5 | |
Protein Name | Nuclear receptor coactivator 5 | |
Gene Name | NCOA5 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 579 | |
Subcellular Localization | Nucleus. | |
Protein Description | Nuclear receptor coregulator that can have both coactivator and corepressor functions. Interacts with nuclear receptors for steroids (ESR1 and ESR2) independently of the steroid binding domain (AF-2) of the ESR receptors, and with the orphan nuclear receptor NR1D2. Involved in the coactivation of nuclear steroid receptors (ER) as well as the corepression of MYC in response to 17-beta-estradiol (E2).. | |
Protein Sequence | MNTAPSRPSPTRRDPYGFGDSRDSRRDRSPIRGSPRREPRDGRNGRDARDSRDIRDPRDLRDHRHSRDLRDHRDSRSVRDVRDVRDLRDFRDLRDSRDFRDQRDPMYDRYRDMRDSRDPMYRREGSYDRYLRMDDYCRRKDDSYFDRYRDSFDGRGPPGPESQSRAKERLKREERRREELYRQYFEEIQRRFDAERPVDCSVIVVNKQTKDYAESVGRKVRDLGMVVDLIFLNTEVSLSQALEDVSRGGSPFAIVITQQHQIHRSCTVNIMFGTPQEHRNMPQADAMVLVARNYERYKNECREKEREEIARQAAKMADEAILQERERGGPEEGVRGGHPPAIQSLINLLADNRYLTAEETDKIINYLRERKERLMRSSTDSLPGPISRQPLGATSGASLKTQPSSQPLQSGQVLPSATPTPSAPPTSQQELQAKILSLFNSGTVTANSSSASPSVAAGNTPNQNFSTAANSQPQQRSQASGNQPPSILGQGGSAQNMGPRPGAPSQGLFGQPSSRLAPASNMTSQRPVSSTGINFDNPSVQKALDTLIQSGPALSHLVSQTTAQMGQPQAPMGSYQRHY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
1 | Acetylation | -------MNTAPSRP -------CCCCCCCC | 10.17 | 21406692 | |
3 | Phosphorylation | -----MNTAPSRPSP -----CCCCCCCCCC | 38.35 | 29255136 | |
6 | Phosphorylation | --MNTAPSRPSPTRR --CCCCCCCCCCCCC | 55.12 | 23401153 | |
9 | Phosphorylation | NTAPSRPSPTRRDPY CCCCCCCCCCCCCCC | 37.48 | 29255136 | |
11 | Phosphorylation | APSRPSPTRRDPYGF CCCCCCCCCCCCCCC | 42.55 | 23401153 | |
13 | Methylation | SRPSPTRRDPYGFGD CCCCCCCCCCCCCCC | 52.30 | 115388787 | |
16 | Phosphorylation | SPTRRDPYGFGDSRD CCCCCCCCCCCCCCC | 29.40 | 28152594 | |
21 | Phosphorylation | DPYGFGDSRDSRRDR CCCCCCCCCCCCCCC | 38.06 | 21130716 | |
24 | Phosphorylation | GFGDSRDSRRDRSPI CCCCCCCCCCCCCCC | 28.27 | 23663014 | |
29 | Phosphorylation | RDSRRDRSPIRGSPR CCCCCCCCCCCCCCC | 29.03 | 29255136 | |
34 | Phosphorylation | DRSPIRGSPRREPRD CCCCCCCCCCCCCCC | 12.84 | 29255136 | |
51 | Phosphorylation | NGRDARDSRDIRDPR CCCCCCCCCCCCCHH | 26.71 | 30108239 | |
66 | Phosphorylation | DLRDHRHSRDLRDHR HHHCCCHHHHHHHHC | 27.70 | 24719451 | |
75 | Phosphorylation | DLRDHRDSRSVRDVR HHHHHCCCCCCCCCC | 26.81 | 27251275 | |
77 | Phosphorylation | RDHRDSRSVRDVRDV HHHCCCCCCCCCCCH | 26.00 | 24719451 | |
96 | Phosphorylation | DFRDLRDSRDFRDQR HHHHHHHCCCHHHHC | 27.58 | 23401153 | |
107 | Phosphorylation | RDQRDPMYDRYRDMR HHHCCHHHHHHHHHH | 11.58 | - | |
110 | Phosphorylation | RDPMYDRYRDMRDSR CCHHHHHHHHHHHCC | 14.20 | 26074081 | |
116 | Phosphorylation | RYRDMRDSRDPMYRR HHHHHHHCCCCCCCC | 28.37 | 23401153 | |
121 | Phosphorylation | RDSRDPMYRREGSYD HHCCCCCCCCCCCHH | 16.35 | 26074081 | |
126 | Phosphorylation | PMYRREGSYDRYLRM CCCCCCCCHHHHCCH | 21.07 | 23401153 | |
127 | Phosphorylation | MYRREGSYDRYLRMD CCCCCCCHHHHCCHH | 18.46 | 26329039 | |
130 | Phosphorylation | REGSYDRYLRMDDYC CCCCHHHHCCHHHHH | 8.86 | 23403867 | |
136 | Phosphorylation | RYLRMDDYCRRKDDS HHCCHHHHHHCCCCC | 5.42 | - | |
143 | Phosphorylation | YCRRKDDSYFDRYRD HHHCCCCCHHHHCCC | 37.52 | 21815630 | |
144 | Phosphorylation | CRRKDDSYFDRYRDS HHCCCCCHHHHCCCC | 19.25 | 23186163 | |
148 | Phosphorylation | DDSYFDRYRDSFDGR CCCHHHHCCCCCCCC | 22.18 | 23927012 | |
151 | Phosphorylation | YFDRYRDSFDGRGPP HHHHCCCCCCCCCCC | 19.08 | 23401153 | |
162 | Phosphorylation | RGPPGPESQSRAKER CCCCCHHHHHHHHHH | 36.27 | 21815630 | |
164 | Phosphorylation | PPGPESQSRAKERLK CCCHHHHHHHHHHHH | 43.41 | 25850435 | |
184 | Phosphorylation | REELYRQYFEEIQRR HHHHHHHHHHHHHHH | 12.17 | - | |
207 | Acetylation | CSVIVVNKQTKDYAE CEEEEEECCCHHHHH | 47.97 | 25953088 | |
215 | Phosphorylation | QTKDYAESVGRKVRD CCHHHHHHHHHHHHH | 23.00 | 25159151 | |
265 | Phosphorylation | QQHQIHRSCTVNIMF CCCCCCCCCEEEECC | 10.44 | 23403867 | |
267 | Phosphorylation | HQIHRSCTVNIMFGT CCCCCCCEEEECCCC | 20.17 | 23403867 | |
274 | Phosphorylation | TVNIMFGTPQEHRNM EEEECCCCHHHHCCC | 15.55 | 23401153 | |
298 | Acetylation | ARNYERYKNECREKE HHHHHHHHHHHHHHH | 53.11 | 26051181 | |
316 | Sulfoxidation | IARQAAKMADEAILQ HHHHHHHHHHHHHHH | 4.95 | 21406390 | |
362 | Ubiquitination | LTAEETDKIINYLRE CCHHHHHHHHHHHHH | 53.56 | 29967540 | |
362 | Acetylation | LTAEETDKIINYLRE CCHHHHHHHHHHHHH | 53.56 | 25953088 | |
377 | Phosphorylation | RKERLMRSSTDSLPG HHHHHHHHCCCCCCC | 24.51 | 25159151 | |
378 | Phosphorylation | KERLMRSSTDSLPGP HHHHHHHCCCCCCCC | 26.35 | 25159151 | |
379 | Phosphorylation | ERLMRSSTDSLPGPI HHHHHHCCCCCCCCC | 30.74 | 23927012 | |
381 | Phosphorylation | LMRSSTDSLPGPISR HHHHCCCCCCCCCCC | 36.23 | 23927012 | |
387 | Phosphorylation | DSLPGPISRQPLGAT CCCCCCCCCCCCCCC | 28.17 | 23927012 | |
394 | Phosphorylation | SRQPLGATSGASLKT CCCCCCCCCCCCCCC | 26.37 | 21406692 | |
395 | Phosphorylation | RQPLGATSGASLKTQ CCCCCCCCCCCCCCC | 31.65 | 21406692 | |
395 | O-linked_Glycosylation | RQPLGATSGASLKTQ CCCCCCCCCCCCCCC | 31.65 | 30059200 | |
398 | Phosphorylation | LGATSGASLKTQPSS CCCCCCCCCCCCCCC | 33.64 | 27050516 | |
401 | Phosphorylation | TSGASLKTQPSSQPL CCCCCCCCCCCCCCC | 51.51 | 26074081 | |
401 | O-linked_Glycosylation | TSGASLKTQPSSQPL CCCCCCCCCCCCCCC | 51.51 | 30059200 | |
404 | Phosphorylation | ASLKTQPSSQPLQSG CCCCCCCCCCCCCCC | 31.61 | 16094384 | |
405 | Phosphorylation | SLKTQPSSQPLQSGQ CCCCCCCCCCCCCCC | 42.36 | 26074081 | |
410 | Phosphorylation | PSSQPLQSGQVLPSA CCCCCCCCCCCCCCC | 38.59 | 26074081 | |
416 | Phosphorylation | QSGQVLPSATPTPSA CCCCCCCCCCCCCCC | 40.38 | 25159151 | |
416 | O-linked_Glycosylation | QSGQVLPSATPTPSA CCCCCCCCCCCCCCC | 40.38 | 30059200 | |
418 | Phosphorylation | GQVLPSATPTPSAPP CCCCCCCCCCCCCCC | 31.84 | 25159151 | |
418 | O-linked_Glycosylation | GQVLPSATPTPSAPP CCCCCCCCCCCCCCC | 31.84 | 30059200 | |
420 | Phosphorylation | VLPSATPTPSAPPTS CCCCCCCCCCCCCCC | 26.06 | 16094384 | |
420 | O-linked_Glycosylation | VLPSATPTPSAPPTS CCCCCCCCCCCCCCC | 26.06 | 30059200 | |
422 | O-linked_Glycosylation | PSATPTPSAPPTSQQ CCCCCCCCCCCCCHH | 56.75 | 30059200 | |
422 | Phosphorylation | PSATPTPSAPPTSQQ CCCCCCCCCCCCCHH | 56.75 | 26074081 | |
426 | Phosphorylation | PTPSAPPTSQQELQA CCCCCCCCCHHHHHH | 37.80 | 26074081 | |
426 | O-linked_Glycosylation | PTPSAPPTSQQELQA CCCCCCCCCHHHHHH | 37.80 | 30059200 | |
427 | O-linked_Glycosylation | TPSAPPTSQQELQAK CCCCCCCCHHHHHHH | 35.32 | 30059200 | |
427 | Phosphorylation | TPSAPPTSQQELQAK CCCCCCCCHHHHHHH | 35.32 | 26074081 | |
437 | O-linked_Glycosylation | ELQAKILSLFNSGTV HHHHHHHHHHHCCEE | 34.09 | 30059200 | |
449 | O-linked_Glycosylation | GTVTANSSSASPSVA CEEEECCCCCCCCCC | 29.72 | 30059200 | |
449 | Phosphorylation | GTVTANSSSASPSVA CEEEECCCCCCCCCC | 29.72 | 28348404 | |
450 | Phosphorylation | TVTANSSSASPSVAA EEEECCCCCCCCCCC | 32.36 | 28348404 | |
450 | O-linked_Glycosylation | TVTANSSSASPSVAA EEEECCCCCCCCCCC | 32.36 | 30059200 | |
452 | Phosphorylation | TANSSSASPSVAAGN EECCCCCCCCCCCCC | 21.47 | 28348404 | |
454 | O-linked_Glycosylation | NSSSASPSVAAGNTP CCCCCCCCCCCCCCC | 23.15 | 30059200 | |
454 | Phosphorylation | NSSSASPSVAAGNTP CCCCCCCCCCCCCCC | 23.15 | 28348404 | |
460 | Phosphorylation | PSVAAGNTPNQNFST CCCCCCCCCCCCCCC | 23.77 | 29802988 | |
460 | O-linked_Glycosylation | PSVAAGNTPNQNFST CCCCCCCCCCCCCCC | 23.77 | 30059200 | |
471 | O-linked_Glycosylation | NFSTAANSQPQQRSQ CCCCCCCCCHHHHHH | 38.21 | 30059200 | |
477 | Phosphorylation | NSQPQQRSQASGNQP CCCHHHHHHHCCCCC | 26.26 | - | |
500 | Methylation | SAQNMGPRPGAPSQG CCCCCCCCCCCCCCC | 36.23 | 115484617 | |
505 | Phosphorylation | GPRPGAPSQGLFGQP CCCCCCCCCCCCCCC | 36.02 | - | |
515 | Methylation | LFGQPSSRLAPASNM CCCCCHHHCCCCCCC | 38.93 | 115484625 | |
520 | Phosphorylation | SSRLAPASNMTSQRP HHHCCCCCCCCCCCC | 26.52 | 29978859 | |
523 | Phosphorylation | LAPASNMTSQRPVSS CCCCCCCCCCCCCCC | 26.42 | 29978859 | |
524 | Phosphorylation | APASNMTSQRPVSST CCCCCCCCCCCCCCC | 17.27 | 29978859 | |
529 | Phosphorylation | MTSQRPVSSTGINFD CCCCCCCCCCCCCCC | 25.51 | 29978859 | |
530 | Phosphorylation | TSQRPVSSTGINFDN CCCCCCCCCCCCCCC | 30.77 | 24719451 | |
530 | O-linked_Glycosylation | TSQRPVSSTGINFDN CCCCCCCCCCCCCCC | 30.77 | 30059200 | |
531 | Phosphorylation | SQRPVSSTGINFDNP CCCCCCCCCCCCCCH | 34.28 | 29978859 | |
539 | Phosphorylation | GINFDNPSVQKALDT CCCCCCHHHHHHHHH | 43.35 | 29978859 | |
546 | Phosphorylation | SVQKALDTLIQSGPA HHHHHHHHHHHHCHH | 26.98 | 20068231 | |
550 | Phosphorylation | ALDTLIQSGPALSHL HHHHHHHHCHHHHHH | 39.49 | 22210691 | |
555 | Phosphorylation | IQSGPALSHLVSQTT HHHCHHHHHHHHHHH | 19.51 | 20068231 | |
559 | Phosphorylation | PALSHLVSQTTAQMG HHHHHHHHHHHHHCC | 28.33 | 20068231 | |
561 | Phosphorylation | LSHLVSQTTAQMGQP HHHHHHHHHHHCCCC | 19.32 | 20068231 | |
562 | Phosphorylation | SHLVSQTTAQMGQPQ HHHHHHHHHHCCCCC | 13.78 | 20068231 | |
574 | Phosphorylation | QPQAPMGSYQRHY-- CCCCCCCCCCCCC-- | 16.31 | 20068231 | |
575 | Phosphorylation | PQAPMGSYQRHY--- CCCCCCCCCCCC--- | 12.11 | 20068231 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NCOA5_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NCOA5_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NCOA5_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NCOA5_HUMAN | NCOA5 | physical | 20211142 | |
NCOA5_HUMAN | NCOA5 | physical | 25416956 | |
SYT16_HUMAN | SYT16 | physical | 25416956 | |
KHDR2_HUMAN | KHDRBS2 | physical | 25416956 | |
AMZ2_HUMAN | AMZ2 | physical | 26186194 | |
GALC_HUMAN | GALC | physical | 26186194 | |
NCOA5_HUMAN | NCOA5 | physical | 21516116 | |
GALC_HUMAN | GALC | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-3; SER-9; THR-379 AND SER-381, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378; THR-379 ANDSER-381, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-3; SER-9; THR-379 AND SER-381, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-378 AND SER-381, ANDMASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-377 AND SER-387, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-127 AND SER-151, ANDMASS SPECTROMETRY. | |
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry."; Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.; Nat. Methods 2:591-598(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-404 AND THR-420, ANDMASS SPECTROMETRY. |